COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 2201: Articles 22001-22010  | Next

An easy, reliable and rapid SARS-CoV2 RT-LAMP based test for Point-of-Care and diagnostic lab
AR GOUILH, M., CASSIER, R., MAILLE, E., Schanen, C., ROCQUE, L.-M., VABRET, A.
10.1101/2020.09.25.20200956 — Posted: 2020-09-25
Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer
Singh, N. K., Ray, P., Carlin, A. F., Magallanes, C., Morgan, S., Laurent, L. C., Aronoff-Spencer, E., Hall, D. A.
10.1101/2020.09.24.20200394 — Posted: 2020-09-25 Discussion: Offsite
Performance of a point of care test for detecting IgM and IgG antibodies against SARS-CoV-2 and seroprevalence in blood donors and health care workers in Panama
Villarreal, A., Rangel, G., Zhang, X., Wong, D., De La Guardia, C., Britton, G., Llanes, P., Restrepo, C. M., Perez, A., Oviedo, D., Carreira, M. B., Skildsen, G., Sambrano, D., Zaldivar, Y., Franco, D., Lopez Verges, S., Zhang, D., Fan, F., Wang, B., Saez Llorens, X., DeAntonio, R., Torres-Atencio, I., Ortega-Barria, E., Kosagisharaf, R., Lleonart, R., Chong, L., Goodridge, A., COVID-19 SEROLOGY COLLABORATOR GROUP
10.1101/2020.09.25.20201459 — Posted: 2020-09-25 Discussion: Onsite
Serum SARS-CoV-2 nucleocapsid antigen detection is essential for primary diagnostics of SARS-CoV-2-associated pneumonia
Lebedin, Y. S., Lyang, O. V., Galstyan, A. G., Belousov, V. V., Rebrikov, D. V.
10.1101/2020.09.24.20200303 — Posted: 2020-09-25
COVID-19 mortality rate in Russia: forecasts and reality evaluation
Lifshits, M., Neklyudova, N.
10.1101/2020.09.25.20201376 — Posted: 2020-09-25
Reproductive Maternal and Newborn Health providers assessment of facility preparedness and its Determinants during the COVID-19 pandemic in Lagos, Nigeria
Ameh, C. A., Banke-Thomas, A. A., Balogun, M., Makwe, C. C., Afolabi, B.
10.1101/2020.09.24.20201319 — Posted: 2020-09-25
Personal protective equipment for reducing the risk of COVID-19 infection among healthcare workers involved in emergency trauma surgery during the pandemic: an umbrella review
Griswold, D. P., Gempeler, A., Kolias, A., Hutchinson, P., Rubiano, A.
10.1101/2020.09.24.20201293 — Posted: 2020-09-25
Face Masks, Public Policies and Slowing the Spread of COVID-19: Evidence from Canada
Karaivanov, A., Lu, S. E., Shigeoka, H., Chen, C., Pamplona, S.
10.1101/2020.09.24.20201178 — Posted: 2020-09-25 Discussion: Onsite
When it is available, will we take it? Public perception of hypothetical COVID-19 vaccine in Nigeria
Adebisi, Y. A., Alaran, A. J., Bolarinwa, O. A., Akande-Sholabi, W., Lucero-Prisno, D. E.
10.1101/2020.09.24.20200436 — Posted: 2020-09-25
A low-cost, rapidly scalable, emergency use ventilator for the COVID-19 crisis
Raymond, S. J., Wesolowski, T., Baker, S., Liu, Y., Edmunds, J. L., Bustamante, M. J., Ley, B., Free, D., Maharbiz, M., Van Wert, R., Cornfield, D. N., Camarillo, D. B.
10.1101/2020.09.23.20199877 — Posted: 2020-09-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).